Explore 3 Stock Ideas & Industry Insights Download Free Report

Baird Medical Investment Holdings Limited

US BDMDW

0.115USD
0.00(0%)

Last update at 2026-06-03T13:30:00Z

Day Range

0.120.12
LowHigh

52 Week Range

0.040.19
LowHigh

Fundamentals

  • Previous Close 0.12
  • Market Cap0.00000M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA0.92M
  • Revenue TTM31.86M
  • Revenue Per Share TTM1.23
  • Gross Profit TTM 27.70M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 14.09M 12.36M 14.52M 12.61M
Minority interest -0.14473M -0.11220M -0.20622M -0.09397M
Net income 12.45M 10.55M 12.57M 10.09M
Selling general administrative 9.96M 8.89M 10.15M 10.22M
Selling and marketing expenses - - - -
Gross profit 32.65M 27.23M 28.04M 23.18M
Reconciled depreciation 1.51M 1.38M 1.47M 1.40M
Ebit - - - -
Ebitda - - - -
Depreciation and amortization - - - -
Non operating income net other - - - -
Operating income 15.32M 12.65M 15.01M 13.09M
Other operating expenses - - - -
Interest expense 0.58M 0.29M 0.30M 0.15M
Tax provision 1.49M 1.70M 1.75M 2.42M
Interest income 0.00039M 0.00156M 0.00855M 0.00233M
Net interest income -0.57636M -0.28427M -0.29072M -0.15160M
Extraordinary items - - - -
Non recurring - - - -
Other items - - - -
Income tax expense - - - -
Total revenue 37.04M 31.46M 35.09M 27.72M
Total operating expenses 21.72M 18.80M 20.08M 14.63M
Cost of revenue 4.38M 4.23M 7.05M 4.54M
Total other income expense net -0.65166M -0.01021M -0.19458M -0.33508M
Discontinued operations - - - -
Net income from continuing ops 12.60M 10.66M 12.77M 10.18M
Net income applicable to common shares - - - -
Preferred stock and other adjustments - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 77.96M 56.71M 42.62M 25.28M
Intangible assets 0.02M 0.03M 0.05M 0.06M
Earning assets - - - -
Other current assets 0.30M 0.12M 0.20M 0.30M
Total liab 38.20M 21.00M 16.84M 10.26M
Total stockholder equity 39.66M 35.75M 25.93M 15.38M
Deferred long term liab - - - -
Other current liab - - - -
Common stock - - - -
Capital stock 0.00259M 0.00256M 0.00294M 0.00000M
Retained earnings 26.76M 14.39M 3.96M -6.77838M
Other liab - - - -
Good will 0.06M 0.06M 0.06M 0.07M
Other assets - - - -
Cash 2.97M 1.51M 1.71M 3.03M
Cash and equivalents - - - -
Total current liabilities 34.62M 18.98M 16.02M 9.77M
Current deferred revenue - - - -
Net debt 17.51M 9.09M 4.52M -
Short term debt - - - -
Short long term debt 17.03M 8.98M 6.23M 2.04M
Short long term debt total - - - -
Other stockholder equity - - - -
Property plant equipment - - - -
Total current assets 61.42M 40.08M 33.76M 21.45M
Long term investments - - - -
Net tangible assets - - - -
Short term investments - - - -
Net receivables 46.58M 31.10M 24.37M 11.17M
Long term debt 3.44M 1.61M - -
Inventory 1.30M 1.14M 1.29M 3.06M
Accounts payable 1.25M 0.55M 0.22M 0.34M
Total permanent equity - - - -
Noncontrolling interest in consolidated entity - - - -
Temporary equity redeemable noncontrolling interests - - - -
Accumulated other comprehensive income - - - -
Additional paid in capital - - - -
Common stock total equity - - - -
Preferred stock total equity - - - -
Retained earnings total equity - - - -
Treasury stock - - - -
Accumulated amortization - - - -
Non currrent assets other 0.12M 0.15M 0.05M 0.08M
Deferred long term asset charges - - - -
Non current assets total 16.55M 16.63M 8.85M 3.83M
Capital lease obligations 0.40M 0.92M 1.21M 0.89M
Long term debt total - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -2.85368M -2.63849M -5.92146M -1.38708M
Change to liabilities - - - -
Total cashflows from investing activities - - - -
Net borrowings 10.31M 4.47M 4.46M -0.08858M
Total cash from financing activities 10.72M 3.46M 4.41M -1.92615M
Change to operating activities - - - -
Net income 12.45M 10.55M 12.57M 10.09M
Change in cash 1.46M -0.20044M -1.32123M 1.96M
Begin period cash flow 1.51M 1.71M 3.03M 1.07M
End period cash flow 2.97M 1.51M 1.71M 3.03M
Total cash from operating activities -6.31311M -1.01996M 0.49M 5.26M
Issuance of capital stock 2.90M 0.00000M 0.00000M -
Depreciation 1.51M 1.38M 1.47M 1.40M
Other cashflows from investing activities - - - -
Dividends paid - - 0.00000M -5.42568M
Change to inventory -0.18754M 0.11M 1.57M -2.19895M
Change to account receivables -17.79975M -9.67451M -14.83933M -2.93979M
Sale purchase of stock - - - -
Other cashflows from financing activities - - - -
Change to netincome - - - -
Capital expenditures 2.85M 2.64M 5.95M 1.39M
Change receivables - - - -
Cash flows other operating - - - -
Exchange rate changes - - - -
Cash and cash equivalents changes - - - -
Change in working capital -21.69772M -14.85608M -14.04929M -6.56832M
Stock based compensation - - - -
Other non cash items - - - -
Free cash flow -9.16679M -3.65845M -5.46816M 3.87M

Peer Comparison

Sector: Industry:

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x)
BDMDW
Baird Medical Investment Holdings Limited
- -% 0.12 - - - -
DOGEF
Orsted A/S
-1.046 4.02% 25.00 28.82 0.66 6.50 0.07 3.88 15.58
NCRRP
NCR Corp Pref A
- -% 1002.00 1034.35 - - -
TBB
AT&T Inc. 5.35% GLB NTS 66
- -% 20.76 4.60 - - -
CCZ
Comcast Holdings Corp
0.21 0.32% 65.15 55.07 - - -

Reports Covered

Stock Research & News

Profile

Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; long microwave ablation needles; and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, as well as soft tissue ablation. It sells its products through third-party distributors. Baird Medical Investment Holdings Limited was founded in 2012 and is based in Guangzhou, China.

Baird Medical Investment Holdings Limited

Baide Building, Building 11, Guangzhou, China

Key Executives

Name Title Year Born
Ms. Haimei Wu Chairwoman of the Board of Directors & CEO 1982
Ms. Quan Qiu Chief Administrative Officer & Executive Director 1993
Mr. Wei Hou Executive Director 1970
Ms. Jie Li Acting Chief Financial Officer 1988
Mr. Rongjian Lu CTO & Deputy GM 1967
Mr. Mark S. Saxton Chief Executive Officer U.S. Subsidiary 1965

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.